Weight based ribavirin with sofosbuvir and daclatasvir for 12 weeks for patients with Genotype 3 Hepatitis C and cirrhosis: An analysis of efficacy and long-term clinical outcomes
Journal article published in 2017 by
Chiara Mazzarelli,
Kate Childs,
Sarah Montague,
Geoffrey M. Dusheiko,
Kosh Agarwal 
,
Mary Cannon
,
Mary Cannon
